What challenges did HSO face before AI implementation?

Sluggish drug development cycles hindered by manual clinical and regulatory processes. Operational inefficiencies in managing trial, molecular, and supply chain data. Complex compliance requirements (cGMP, FDA, CFR) demanded robust data traceability. Fragmented data systems across global research and manufacturing partners.

What was the impact of the AI solution?

Improved R&D and trial productivity, lowering time-to-market for new drugs. Enhanced regulatory compliance and data quality across the product lifecycle. Optimized global supply chain analytics and product launch strategies. Empowered pharmaceutical companies with scalable digital platforms for innovation.

Source

Microsoft

HSO enables AI-powered process optimization for pharmaceutical R&D and compliance

Use case typeClinical documentationUpdated Jun 13, 2026

HSO, a global consulting and technology firm, has implemented advanced Microsoft technologies to support innovation, process automation, and regulatory compliance for pharmaceutical companies. By deploying Microsoft Copilot, Microsoft Fabric, Azure AI, and Gen AI, HSO's solutions automate key aspects of drug development and clinical trials, such as data management, adverse event reporting, patient engagement, and FDA submissions. HSO also partners with Merit Solutions for further integration and support. The solution includes analytics-driven product launch strategies and predictive supply chain insights. This digital transformation improves R&D productivity, enables faster time-to-market for products, efficiently manages molecular and clinical data, and ensures quality and compliance in life sciences operations.

Organization: HSO
Industry: Pharma
Location: United Kingdom

Reported outcomes

Strategic outcomes

New product / capabilityAutomated clinical trial and reporting workflowsRisk & complianceEnhanced regulatory compliance and data qualityBetter decisions & insightOptimized supply chain analytics and launch strategiesScale & capacityEnabled scalable digital innovation platforms

Primary read

Use case focus

Showing 2 of 2

1Automated clinical trial and adverse event data management
2AI-powered FDA submission and compliance automation

Sluggish drug development cycles hindered by manual clinical and regulatory processes.
Operational inefficiencies in managing trial, molecular, and supply chain data.
Complex compliance requirements (cGMP, FDA, CFR) demanded robust data traceability.
Fragmented data systems across global research and manufacturing partners.

Deployed Microsoft Copilot and Microsoft Fabric for proof-of-concept trials.
Automated clinical trial compilation and adverse event reporting using AI and Fabric.
Enabled predictive patient support and FDA submissions automation via Copilot.
Integrated research and supply chain data with scalable, multi-cloud architecture.

Technologies

Microsoft Copilot Microsoft Fabric Azure AI

Improved R&D and trial productivity, lowering time-to-market for new drugs.
Enhanced regulatory compliance and data quality across the product lifecycle.
Optimized global supply chain analytics and product launch strategies.
Empowered pharmaceutical companies with scalable digital platforms for innovation.

Architecture

Utilizes Microsoft Fabric to centralize and manage R&D and supply chain data from multiple sources. AI-driven automation (via Copilot) is layered to automate trial data compilation, adverse event tracking, and submission processes. Integration across cloud platforms (primarily Microsoft) ensures end-to-end compliance and analytics for drug development, patient care, and business partners.

Implementation partners1

Merit Solutions

Sources & evidence1

Groundedness: 2/5

Primary source

AI-generated summary. Verify important details with the linked sources before relying on this case.

Explore related AI use cases

Customer evidence